European Federation of Pharmaceutical Industries and Associations
Trade and business associations · Luxembourg
In these lists: Biggest budgets, Most meetings, Medicines
- Declared lobbying cost
- €6,000,000 – €6,499,999 Financial year 01/2025-12/2025
- Commission meetings
- 51
- Full-time staff on EU lobbying
- 13.4
- European Parliament access passes
- 11
- Registered since
- 4 Mar 2009
Public records onlyWhat this means
Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself
Fields of interest
Budget, Business and industry, Climate action, Competition, Consumers, Customs, Digital economy and society, Employment and social affairs, Environment, External relations, Humanitarian aid and civil protection, Institutional affairs, International co-operation and development, Public health, Research and innovation, Single market, Trade, Trans-European Networks
Medicines and food topics they name
EU medicines law, Orphan and paediatric medicine incentives, Health technology assessment, Antibiotics and antimicrobials
EU laws and policies they declare following14
- Any health or pharmaceutical policy stemming from the European institutions, such as - but not exclusive - Industrial Policy, Pharmaceutical Strategy, pharmaceutical, orphan and paediatrics legislati…
- Main EU legislative proposals or policies targeted (a non-exhaustive list)
- A Pharmaceutical Strategy for Europe – over 50 legislative and non-legislative proposals
- Directive 2001/83/EC on the Community code relating to medicinal products for human use
- Regulation (EC) No 726/2004 of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and…
- Regulation (EC) No 141/2000 of the European Parliament and of the Council on orphan medicinal products.
- Regulation (EC) No 1901/2006 of the European Parliament and of the Council on medicinal products for paediatric use
- In addition, we also follow for example:
- Clinical Trial Regulation
- EMA Fees Regulation
- Europe’s Beating Cancer Plan
- European Health Data Space
- HERA Regulation
- SPCs Regulation revision
Meetings with the Commission
Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them